2
Announcements
Trials
Browse
Landscape
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Neoplasms
47
Breast Neoplasms
32
Colorectal Neoplasms
28
Prostatic Neoplasms
27
Lung Neoplasms
17
Hematopoietic and Lymphatic System Neoplasm
13
Hematologic Neoplasms
12
Ovarian Neoplasms
11
Uterine Cervical Neoplasms
7
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Multiple Myeloma
7
Lymphoma
7
Leukemia
7
Head and Neck Neoplasms
6
Endometrial Neoplasms
6
Depression
6
Rectal Neoplasms
5
Pancreatic Neoplasms
5
Leukemia, Myeloid, Acute
5
Urinary Bladder Neoplasms
4
Mouth Neoplasms
4
Motor Activity
4
Melanoma
4
Malignant Solid Neoplasm
4
Hematopoietic and Lymphoid System Neoplasm
4
Gastrointestinal Neoplasms
4
Colonic Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Anxiety Disorders
4
Advanced Cancer
4
Interventions
Cytarabine
14
fludarabine
13
venetoclax
11
Imatinib Mesylate
9
Cyclophosphamide
8
Azacitidine
8
fludarabine phosphate
7
Busulfan
7
Whole-Body Irradiation
6
Tacrolimus
6
Mycophenolic Acid
6
thymoglobulin
4
ponatinib
4
nilotinib
4
Sirolimus
4
Peripheral Blood Stem Cell Transplantation
4
Methotrexate
4
asciminib
3
aldesleukin
3
Melphalan
3
Interleukin-2
3
Idarubicin
3
Granulocyte Colony-Stimulating Factor
3
Filgrastim
3
Decitabine
3
Bone Marrow Transplantation
3
Antilymphocyte Serum
3
zosuquidar trihydrochloride
2
gilteritinib
2
enasidenib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Leukemia, Myeloid
×
Interviews as Topic
×
Clear all
NCT05309018
2024-05-23
LAMIPA
Centre Hospitalier Régional Metz-Thionville
Withdrawn